Physician profile
Mark Lightowler
NPI 1376000869
$957.33
in general payments reported to CMS, 2019-2025
9 companies · $147 in 2025
The $147 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $141 · 2023: $364 · 2024: $306 · 2025: $147.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $816.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $816.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $241.74 | 2023-2024 | Mako, Gamma, T2 Alpha |
| Davol INC. | $159.19 | 2023 | Arista Ah Flexitip |
| Kerecis Limited | $150.00 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Si-Bone, INC. | $100.56 | 2025 | |
| Medical Device Business Services, INC. | $98.00 | 2022 | |
| Omnilife Science, INC | $61.76 | 2023 | Omnibotics 3.0 |
| Heron Therapeutics, INC. | $57.08 | 2023 | Zynrelef |
| Smith+Nephew, INC. | $46.06 | 2025 | Pico |
| Ethicon US, LLC | $42.94 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Lightowler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.